CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Building A Scalable Global T Cell Manufacturing Platform

  Achieve scalable T cell manufacturing with automation, standardized workflows, and integrated quality control to enable high-yield production, flexible scheduling, and seamless tech transfer.

• Regulatory Considerations For Excipients Used In Lipid Nanoparticles

  Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.

• Life Cycle Assessment Of Extended Use Strategies For Single-Use Assemblies

  Examine how extending the use of single‑use assemblies can significantly reduce emissions, resource consumption, and waste in bioprocessing, offering a data‑backed path toward sustainability.

• Bridging Studies For Producer Cell Line Adoption: Regulatory And Development Perspectives

  Explore how analytical comparability, risk assessment, and bridging strategies can support a smooth and compliant platform transition.

• Comparison Of Constant- And PulsedField Electrophoresis

  Accurate sizing of large DNA fragments is crucial in long‑read sequencing. Examine how different electrophoresis methods perform with 10–20 kb smears and how to choose the most reliable approach.

• Bringing Clinical Trials To Everyone's Backyard

  Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.

• Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy

  The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.

• The Proven, Practical Gateway To Upstream Process Intensification

  N-1 perfusion enables higher inoculum densities, faster production, and reduced costs without altering fed-batch processes. Explore a practical path to intensification for biologics manufacturers.

• Advancing An Integrated Biopharma Workflow Strategy

  Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.

• High-Throughput 90-Minute ELISA

  Discover how one solution can be utilized to measure Human IgG and human IFN gamma, which are key targets in pharmacokinetic studies and immunotherapeutic drug safety testing, in just 90 minutes.